Essa Pharma Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 30
Employees
  • Stock Symbol
  • EPIX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $5.67
  • (As of Wednesday Closing)

Essa Pharma General Information

Description

ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Contact Information

Formerly Known As
ESSA Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Stock Exchange
NAS
Primary Office
  • 999 West Broadway Street
  • Suite 720
  • Vancouver, British Columbia V5Z 1K5
  • Canada
+1 (778) 000-0000

Essa Pharma Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Essa Pharma Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.67 $5.75 $5.21 - $33.84 $253M 44.1M 254K -$0.86

Essa Pharma Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 30-Sep-2021 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019
EV 83,121 149,930 161,249 63,823
Revenue 0 0 0 0
EBITDA (37,836) (36,943) (23,565) (12,142)
Net Income (37,264) (36,805) (23,445) (12,757)
Total Assets 182,609 198,166 80,575 54,573
Total Debt 274 331 59 3,709
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Essa Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Essa Pharma‘s full profile, request access.

Request a free trial

Essa Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of smal
Drug Discovery
Vancouver, Canada
30 As of 2021
00000
000000000 00000

00000000

empor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitatio
0000 00000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000000000000
Cambridge, MA
000 As of 0000
00000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Essa Pharma Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merrimack Pharmaceuticals Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
00000 000000000 Formerly VC-backed Boulder, CO 000 00000 000000&0 00000
0000000 Formerly VC-backed Austin, TX 00 000.00 000000000 000.00
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 27 competitors. Get the full list »

Essa Pharma Patents

Essa Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210323931-A1 Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof Pending 17-Apr-2020 0000000000
US-20210332016-A1 Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof Pending 17-Apr-2020 0000000000
AU-2020248105-A1 Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof Pending 28-Mar-2019 000000000
CA-3134545-A1 Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof Pending 28-Mar-2019 A61K45/06

Essa Pharma Executive Team (9)

Name Title Board Seat Contact Info
David Parkinson MD President, Chief Executive Officer & Board Member
David Wood Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Peter Virsik Chief Operating Officer, Operations & Executive Vice President
Alessandra Cesano Ph.D Chief Medical Officer
You’re viewing 4 of 9 executive team members. Get the full list »

Essa Pharma Board Members (13)

Name Representing Role Since
0000 000000 Self Board Member 000 0000
00000 000000000 00 Essa Pharma President, Chief Executive Officer & Board Member 000 0000
00000000 000000 Self Board Member 000 0000
0000 000000 Self Board Member 000 0000
0000 000000 Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Essa Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Essa Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Essa Pharma‘s full profile, request access.

Request a free trial

Essa Pharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 31-Jul-2019 0000000000 000.00 Drug Discovery
To view Essa Pharma’s complete acquisitions history, request access »

Essa Pharma Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Drug Discovery Malvern, PA 0000
To view Essa Pharma’s complete subsidiaries history, request access »